Synergy CHC Corp. Material Event - What Happened

This report explains the latest news about Synergy CHC Corp. in plain English, so you can understand the situation without needing a finance degree.

1. What happened?

Synergy CHC Corp. (SNYR), a company that sells over-the-counter health products, received a warning from the Nasdaq Stock Market. The company’s stock price stayed below $1.00 for 30 business days in a row. This violates Nasdaq’s rule requiring a minimum $1.00 share price.

2. When did it happen?

Nasdaq sent the official written notice to the company on May 15, 2026.

3. Why does this matter?

This notice acts as a "yellow flag" for the company’s status on the Nasdaq. It does not immediately stop the stock from trading; shares still trade under the symbol "SNYR." However, it starts a clock. If the company cannot fix this, it faces delisting. Delisting would make it harder to trade the stock on a major national exchange and could negatively impact the stock's liquidity.

4. Who is affected?

• Investors: Shareholders face increased uncertainty. The stock may become more volatile as the market reacts to the deadline. The company might also consider a "reverse stock split"—combining shares to mathematically increase the price—which is a common strategy but can change the structure of your investment.
• Customers & Employees: This is a corporate regulatory issue, not a change in business operations. It does not change how the company makes or sells its health products, nor does it change daily business activities.

5. What happens next?

Synergy has 180 days to fix the issue, with a deadline of November 11, 2026. To comply, the stock price must close at $1.00 or higher for at least 10 business days in a row before that date. If they miss the deadline, they might be eligible for another 180-day grace period if they meet other specific Nasdaq requirements. The company has not yet announced a specific plan to address the price, so they are currently in a "wait and see" phase.

6. What should investors know?

A deficiency notice is a standard regulatory step, not an immediate delisting. Many companies resolve this by improving their business performance or by using a reverse stock split to boost the share price.

Key takeaway for your decision-making: Keep a close eye on the company’s official press releases over the next few months. Any announcement regarding a strategic plan to regain compliance or a shift in business performance will likely cause the stock price to move significantly. If you are holding or considering buying, be prepared for higher-than-usual volatility until the $1.00 threshold is met.

Disclaimer: This summary is for informational purposes only and does not constitute financial advice. Always do your own research before making investment decisions.